CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 178 filers reported holding CRISPR THERAPEUTICS AG in Q1 2019. The put-call ratio across all filers is 1.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $81,652,000 | +6210.0% | 1,077,483 | +3431.6% | 2.60% | +1827.4% |
| Q1 2020 | $1,294,000 | -98.3% | 30,510 | -98.1% | 0.14% | -98.2% |
| Q2 2019 | $75,843,000 | +13.0% | 1,610,250 | -14.3% | 7.66% | +23.9% |
| Q1 2019 | $67,092,000 | +1024.4% | 1,878,277 | +799.3% | 6.18% | +936.0% |
| Q4 2018 | $5,967,000 | -73.1% | 208,850 | -58.2% | 0.60% | -70.1% |
| Q3 2018 | $22,175,000 | – | 500,000 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |